In a rare move, a Houston Methodist researcher is sharing his recipe for a new, more affordable way to make nanoparticles. This will empower any laboratory in the world to easily create similar nanoparticles and could lead to a whole new way of delivering biotherapeutic drugs and do it more quickly.
“We’re the only lab in the world doing this,” said Ennio Tasciotti, Ph.D., director of the Center for Biomimetic Medicine at the Houston Methodist Research Institute and corresponding author on a paper coming out March 7 in Advanced Materials. “There are several questions about how our system works, and I can’t answer all of them. By giving away the so-called ‘recipe’ to make biomimetic nanoparticles, a lot of other labs will be able to enter this field and may provide additional solutions and applications that are beyond the reach of only one laboratory. You could say it’s the democratization of nanotechnology.”
In the article, Tasciotti and his colleagues show how to standardize nanoparticle production to guarantee stability and reproducibility, while increasing yield. Eliminating the need for multi-million-dollar facilities, Tasciotti and his team demonstrate this using a readily available and relatively affordable piece of benchtop equipment to manufacture nanoparticles in a controlled, adjustable and low-cost manner.
“Nanoparticles are generally made through cryptic protocols, and it’s very often impossible to consistently or affordably reproduce them,” Tasciotti said. “You usually need special, custom-made equipment or procedures that are available to only a few laboratories. We provide step-by-step instructions so that now everybody can do it.”
For decades nanoparticles have been made out of bioinert, or inorganic, substances that don’t interact with the body. In more recent years, nanoparticles were made to be bioactive, meaning they could respond to the environment. Now, Tasciotti is pushing the field forward by creating biomimetic nanoparticles that resemble cell composition and work in synergy with the laws that govern the physiology of the body.
“The body is so smart in the ways it defends itself. The immune system will eventually recognize nanoparticles no matter how well you make them,” Tasciotti said. “In my lab, we make nanoparticles out of the cell membrane of the very same immune cells that patrol the blood stream. When we put these biomimetic, or bioinspired, nanoparticles back in the body, the immune cells do not recognize them as something different, as they’re made of their same building blocks, so there is no adverse response.”
Despite the complexity of this new class of particles, Tasciotti says it’s incredibly simple how they put it together, which is why he decided to publish this paper.
“While our lab will remain fully devoted to this line of research, if somebody else develops some solutions using our protocols that are useful in clinical care, it’s still a good outcome,” he said. “After all, the ultimate reason why we are in translational science is for the benefit of the patients.”
Other researchers collaborating with Tasciotti on this paper include his co-corresponding author Roberto Molinaro, Michael Evangelopoulos, Jessica R. Hoffman, Claudia Corbo, Francesca Taraballi, Jonathan O. Martinez and Kelly A. Hartman from Houston Methodist; Michael Sherman from University of Texas Medical Branch; and Donato Cosco, Giosue’ Costa, Isabella Romeo, Donatella Paolino, Stefano Alcaro from the University “Magna Græcia” of Catanzaro in Italy.
The work was supported by grants from the Cancer Prevention and Research Institute of Texas (RP170466), the NIH’s National Cancer Institute (R56CA213859), the Hearst Foundation and The Cullen Trust for Health Care.
Tasciotti is also the Director of the Center for Musculoskeletal Regeneration at the Houston Methodist Department of Orthopedics and Sport Medicine.
RT @UTHUrology: September is #ProstateCancerAwarenessMonthCheck out one of our residents @leoborr talk about #prostatecancer on @Univisi…
NASCAR driver Kurt Busch is investing in military Veterans to help them ‘reintegrate’ into civilian life https://t.co/6KG9OTICkz via @CNBC
“A nutrient-rich diet can help keep you healthier, longer,” says our clinical dietitian Haley Gale.Here’s what you should know about flaxseed, omega-3 fatty acids and iron. https://t.co/xdTyYd8kaB #endcancer
@LolitaBueno74 We’re so glad to hear this. We are thinking of you both.
“The way I see it, staying on the clinical trial is the least I can do to say ‘thank you’ for the privilege of still being alive,” says David Wight.Here’s why David travels here from Alaska for treatment. https://t.co/c47OxJx4sH #endcancer https://t.co/DCosGdWIj3
Painted feather gifts help Veterans heal wounds of service https://t.co/pJIi3DF41F via #CharKoostaNews
Blind Veteran sees future perfectly clear https://t.co/khdyTynIi9 via #VAntagePoint
Find out what questions doctors should ask as they look for possible vaping complications. https://t.co/beKvoDrpW0 #vaping
A huge congrats to Pooneh Bagher, PhD, assistant professor of medical physiology at the Texas A&M College of Medicine, on her new role with the International Society for Gravitational Physiology!Read more about her position here | https://t.co/62DeZ1sYF4#TAMUHealth https://t.co/5L2FTdX86N
Tune into Dean Nancy Fahrenwald, PhD, RN, PHNA-BC, FAAN, when she speaks about the nursing shortage on the newest episode of Texas A&M Health Talk's The Vantage Point.Spotify → https://t.co/2QbStdnnp0#TAMUHealth https://t.co/O3dCMowkgW
Welcome aboard, @GregWHartman! We are excited about the future and what we can accomplish together.#TAMUHealth https://t.co/duotDxFSa1
A sick kiddo is never fun. Help your children keep the germs at bay with these tips. https://t.co/ttd141QQAV #germs #familymedicine
RT @UTH_CVSurgery: #aorticdiseaseawarenessday prep continues! We have such an interest in the aorta, that we even created an aorta event! F…
Pain in your feet stopping you from completing your workout? See what could be causing the discomfort. https://t.co/zkbUijyHi8 #sportsmedicine #orthopedics
RT @UTH_CVSurgery: #AorticDiseaseAwarenessDay, 5 days out! #Research in Aortic Disease-In Fall 2018, we enrolled the first patient in the A…